web analytics
6.4 C
Munich
Wednesday, October 5, 2022

ProText Mobility, Inc. (OTCMKTS: TXTM) RSA Medical Marijuana Dispensaries RSAMMD Reverse Merger Steady Rise Towards $0.0191 Break

ProText Mobility, Inc. (OTCMKTS: TXTM) is running steadily northbound in recent trading and is looking to take out recent highs of $0.0191. TXTM recently proved itself as one of the biggest runners in small caps moving up over 1000% after the Company announced the long awaited RSAMMD reverse merger when RSA Medical Marijuana Dispensaries RSAMMD™ The more we are learning about RSA Medical Marijuana Dispensaries RSAMMD™ the more interesting it becomes. RSAMMD in Joint Venture with Leeds Boerdery, cultivated hemp and cannabis crops this past season on a combined 1000+ hectares. According to RSAMMD website they produced 35,000 kilograms on 1,000 hectares plot sitting on a 5,000-hectare farm so there is lots of room for expansion. They could also greatly increase their yield per hectare as compared to many Companies that can easily get 1,000 kilos per hectare. Currently trading at a $71 million market valuation TXTM has a lot of room to grow.  

RSAMMD run by CEO Dylon Du Plooy has a lot going on behind the scenes. In August TXTM provided a shareholder update in which CEO Dylon Du Plooy explained how the Company got the Kettles next generation live plant extraction equipment back to the Company’s 5000 Hectare New Castle Farm. Management envisions commercializing this extraction technology for its own purposes, as well as, for potential global licensing. According to Dylon Du Plooy: “Our investigations have conclusively demonstrated that full-spectrum cannabinoids can be extracted using the proprietary Kettle system, with minimal metabolic conversion, paving the way for advancement of medical research using non-psychoactive cannabis.  What has also intrigued us are the findings from prior research and clinical trials that have shown that the Kettle system, when applied to other medicinal plants, can create an extract that is significantly more bioavailable (10-15x) than a standard extract.  This means that our cannabis extract should be more potent while providing a dose that could potentially last up to 24 hours in the bloodstream, which is in-line with prior clinical results using other medicinal plants.  Medically, this opens the door to a line of natural pharmaceuticals derived from cannabis but at a fraction of the price and with potentially superior outcomes.  From a business perspective, an increase of bioavailability in that magnitude can be a game changer for cultivators as it essentially could increase the net yield by a factor of 10-15x per plant, per acre, per farm.” 

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

RSA Medical Marijuana Dispensaries RSAMMD™ is a fully licensed health practitioners, qualified to dispense and prescribe medical cannabis in South Africa. The Company offers superior patient care and 100% Indoor and greenhouse grown cannabis ensuring patients receive clean, safe, and pure medical cannabis products. RSAMMD has 2 commerical licenses, 1 dispensing, importation & prescription license, 2 permits, 1 seed bank cultivar and with an annual production of 35,000 kilograms per year.

In June (reverse merger) Republic of South Africa Medical Marijuana Dispensaries Acquisitions LLC (“RSAMMDA.LLC”) announced it has closed on the acquisition of Protext Mobility, Inc (OTC PINK: TXTM) (A.K.A. Protext Pharma) in a share exchange whereby 100% of capital stock in RSAMMDA.LLC will be exchanged for Preferred Stock in Protext. RSAMMDA.LLC. is a jointly owned company focused on acquistions with two principals, Mr. Dylon Du Plooy and Dr. Ahmed Jamaloodeen (“Dr. J”) who represent the South African business entities of RSAMMD and Leeds Boerdery. RSAMMD is a South African pioneer in the research, cultivation, production and distribution of medical cannabis and cannabinoids. Leeds Boerdery, controlled by Dr. J, owns the 5000 Hectacre New Castle Farm as well as federally issued cannabis and hemp licenses issued by the Government of South Africa. RSAMMD management have taken over the daily operations of Protext headed by Mr. Du Plooy as CEO and Director, and Dr. Jamaloodeen as President and Chairman of the Board. 

In August TXTM provided a shareholder update in which CEO Dylon Du Plooy explained how the Company got the Kettles next generation live plant extraction equipment back to the Company’s 5000 Hectare New Castle Farm. Management envisions commercializing this extraction technology for its wn purposes, as well as, for potential global licensing.  

TXTM is now significantly closer than it ever has been to commercialization in its history. 

Dr. Jamaloodeen commented: “And now, with the acquisition complete Protext has management in place with the knowledge, Government relationships and other, compliance, resources, facilities, biomass, human capital and infrastructure that is invaluable.  The Permits we are in possession of allow for Genus Cannabis Sativa import, export, grow & cultivation, research, testing, developing end product for global distribution, all of which are anticipated to be utilized by Protext with the end goal to commercialize the live plant extraction technology and bring superior end products to the global market. Having technology that’s been proven to increase bioavailability by 10-15x greater is Significant and puts us Miles ahead of all competitors.  Additional testing is anticipated to be conducted over the next few weeks as we are excited to announce the kettle equipment has arrived back at the farm and Now rests safely in the Laboratory it’s new Home. The testing will focus on maximizing yield as well as testing various strains of Genus Cannabis Sativa. We will also begin conducting the R&D using the New Age Extraction Technology for other Indigenous Plant Flora with medicinal properties. 

I feel that the Significance of the Extraction Technology with its 10-15X Bioavailability has been over looked and that is due to the complexity of the science and lack of understanding by the shareholders but in layman’s, terms we stand to produce Natural Plant Base Medicine with 10-15 Times more Bioavailability than current products on the market. As we are focused on the reduction of opioids in the pharmaceutical industry, we look towards the indigenous plant flora for their healing properties and turn back towards natural plant-based medicine from whence it came. 

https://twitter.com/RSAMMD/status/1572312088110051329

To Find out the inside Scoop on TXTM Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

TXTM

Dr.J continued, “As we previously stated, but worth repeating, we entered into this transaction with Protexs we believe there to be numerous synergies by allowing access to certain assets of our established business’ with Protext as well as commercialize the Protext proprietary live plant extraction technology and processes into our existing Genus Cannabis Sativa infrastructure.  Prior to the merger, Protext had collaborated with RSAMMD and Leeds Boerdery, whereby the companies utilized Protext’s proprietary live plant extraction technology along with Kettle extraction equipment to conduct a series of live cannabis extraction testing at New Castle Farm under permits for Genus Cannabis Sativa, with the goal to produce an emulsion rich with cannabinoid but with little to no conversion of THC-A to psychoactive THC.  We undertook a series of tests to prove out that the Kettle system and extraction technologies did what they were supposed to do.  As part of our previous investigations, various tests were completed using live cannabis flower and leaf, rendered into liquid emulsions supplied by the farm in New Castle.  Prior to now, it was hypothecated that processing live Genus Cannabis Sativa under lower temperatures would yield a rich nano-emulsion of phytocannabinoids while retaining the non-psychoactive precursor acid form (THC-A). Our investigations have conclusively demonstrated that full-spectrum cannabinoids can be extracted using the proprietary Kettle system, with minimal metabolic conversion, paving the way for advancement of medical research using non-psychoactive cannabis.  What has also intrigued us are the findings from prior research and clinical trials that have shown that the Kettle system, when applied to other medicinal plants, can create an extract that is significantly more bioavailable (10-15x) than a standard extract.  This means that our cannabis extract should be more potent while providing a dose that could potentially last up to 24 hours in the bloodstream, which is in-line with prior clinical results using other medicinal plants.  Medically, this opens the door to a line of natural pharmaceuticals derived from cannabis but at a fraction of the price and with potentially superior outcomes.  From a business perspective, an increase of bioavailability in that magnitude can be a game changer for cultivators as it essentially could increase the net yield by a factor of 10-15x per plant, per acre, per farm.” 

“All of this work was made possible through existing permits and Infrastructure to conduct research and testing of Genus cannabis sativa at the New Castle Farm, managed and controlled by Dr.J.  We are enthusiastic about commercializing the proprietary extraction technology.  By devising a way to extract the phytocannabinoids without metabolic conversion of THC-A, we can retain the entourage effect and the full medical potential of Genus Cannabis Sativa, but without the psychoactive property delivered by THC.  We believe what we have now shown is a scientifically important milestone and a technology breakthrough that has global significance and we look forward to taking this to commercialization which may include global licensing opportunities to other grow and extraction facilities around the world, This is the turning point of $TXTM in it’s history thus far ” concluded Protext CEO, Mr. Du Plooy. #LetsGoTXTM 

On September 7 TXTM announced its Chairman Dr. Ahmed Jamaloodeen (Dr.J) has received the honor of being appointed as Hemp Production Ambassador.  A business engagement program took place last week including governmental officials where Dr. J gave a keynote speech highlighting the priorities of hemp farming including education, job creation, poverty eradication, and zero waste. 

Dr.J, Protext Chairman and President, commented “It is with great honor to be appointed Hemp Production Ambassador. As Ambassador, one of my roles is to promote with full autonomy and be fully enabled to build the District into a Cannabis/hemp hub as well as support the following initiatives; job creation, poverty eradication, education, attract foreign investment, foreign direct trade initiatives, government to government for corporate enablement. As part of this, last week I had the distinct honor of presenting at a business engagement program centered on Trade and Investment in collaboration with government and business.  Several key points were highlighted to assist towns under the municipality’s oversite including: Help businesses to grow and stay in the community, Identify and support the local business community with capacity-building opportunities, Conducive business environment for service delivery to the community. Community uplifting has always been at the forefront of our mission.  It was highlighted that there were numerous projects set to roll out to boost the local economy, exports and increase job opportunities.  One of the projects included hemp/cannabis production under an MOU signed with a local hemp farmer.” 

“We are pleased to confirm that MOU is with our farm, to be used as a pilot, under our stewardship.  The pilot will become a model that is duplicable, replicable, equitable, exportable and an example to show what other provinces and districts could strive for in using cannabis/hemp farming for community uplift, job creation, poverty eradication, education and much more.  Hemp is a commodity and a plant that the government is backing to boost the economy due to its potential.  While hemp and cannabis flower have many positive medicinal uses, the other parts of the plant have many industrial uses.  We believe factories in our District, our country and globally have the opportunity to introduce hemp into their existing product lines.  We haven’t even begun to scratch the surface on all the opportunities including new technologies that we are developing using live hemp and cannabis plant for processing, extracting and creating end products that should have 10-15x greater bioavailability.  The business case and implications on superior bioavailablity is significant as it relates to lower dosing, and substantial increase in production yield for end products, with lower cost and higher ROI.  We believe Newcastle and the District can become a cannabis/hemp hub with Africa Free Trade Zone coming up and we look forward to being the leadership in the process.  When we talk about the value of human capital, this appointment as Hemp Production Ambassador along with the recent appointment as the National Commodity Chairperson of the largest agricultural union, Protext will see great benefit that the enablement of these appointments represents for their President and Chairman, as government and union collaboration are essentially now wrapped up all in one for corporate enablement,” concluded Dr. J. 

Fore More on TXTM Subscribe Right Now!

Currently trading at a $71 million market valuation TXTM is the perfect RM runner with a far better share structure than HMBL/TSNP did by far and it’s got power TXTM is moving steadily northbound and is a staple among the top most traded stocks in small caps. TXTM recently proved itself as one of the biggest runners in small caps moving up over 1000% after the Company announced the long awaited RSAMMD reverse merger when RSA Medical Marijuana Dispensaries RSAMMD™ RSAMMD run by CEO Dylon Du Plooy has a lot going on behind the scenes. In August TXTM provided a shareholder update in which CEO Dylon Du Plooy explained how the Company got the Kettles next generation live plant extraction equipment back to the Company’s 5000 Hectare New Castle Farm. Management envisions commercializing this extraction technology for its wn purposes, as well as, for potential global licensing. TXTM is steadily marching towards $0.0191, a break over and TXTM could do something really big on a blue-sky breakout. Microcapdaily will be covering RSAMMD as it happens so make sure you subscribe to Microcapdaily right now so you don’t miss it. 

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: we hold no position in TXTM either long or short and we have not been compensated for this article.

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.